The circTLK1/miR‐26a‐5p/DAPK1 regulatory axis highlights the role of circTLK1 in the pathogenesis of PD and provides a new theoretical basis for the development of effective treatments for PD. This evidence concerns the gene DAPK1 and Parkinson disease.